Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.
about
Interventions for hirsutism (excluding laser and photoepilation therapy alone)Spironolactone versus placebo or in combination with steroids for hirsutism and/or acneSpironolactone versus placebo or in combination with steroids for hirsutism and/or acnePoly Cystic Ovarian Syndrome: An Updated OverviewComprehensive clinical management of hirsutism.Interventional studies for polycystic ovarian syndrome in children and adolescents.Hirsutism: an evidence-based treatment update.Aldosterone: a forgotten mediator of the relationship between psychological stress and heart diseaseState of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future?Ovarian hypertension: polycystic ovary syndrome.Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.Spironolactone for hirsutism in polycystic ovary syndrome.Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndromeA systematic review of commonly used medical treatments for hirsutism in women.Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.The metabolic effects of drugs used for the treatment of polycystic ovary syndromeComparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women.Polycystic ovary syndrome: an overview.Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.PCOS in adolescence and type 2 diabetes.Optimal management of polycystic ovary syndrome in adolescence.Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies.Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis.Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.Hyperinsulinaemic androgen excess in adolescent girls
P2860
Q24186393-C9791351-754A-4328-8789-2BD4F8752AFEQ24241760-882C33E3-FDD4-41AC-BB5B-D4048154D121Q24247734-37EC9CFA-3BD3-471D-B833-D1501F819438Q26752564-C2249EDE-CF04-4BA1-BE51-84BFF85EAAA4Q33539381-9818DA47-41EC-4F5D-8734-59FAE09DAA8FQ33996662-557B7F42-43F7-4D9B-A32E-8F14FDFD1DEAQ34422575-4761E1C5-32A2-4723-92F8-39497726E91DQ34997222-A9147CEA-F310-4B5A-9D97-FF145112BB52Q35233754-9D989802-6FD9-43DA-BE25-577250EB07A9Q35352407-74D6E966-8201-4605-BD00-C61D523917A1Q35660296-D410FF7E-1890-4EBF-B018-A94A95DCE2EEQ35927890-C7AE5271-505B-44FF-89D2-309C56ADCC8AQ36217225-FBD0B203-9373-45AA-A617-64CC6CCCB198Q36755392-06C72445-470E-4038-AF95-24767949D18EQ36990797-807D3B12-4E26-45C4-B4A3-A746D0636595Q37193241-88F76999-E9CC-4AAD-86FF-7C04E6A11B27Q37412812-D500277B-C233-45D8-9330-30F77C822E9EQ37591848-C8B4FBAF-6DB8-40B0-8DE4-E7D92597C73AQ37703694-88C99B4D-ABA6-4E7C-A03A-AB1C40D7DE93Q37886072-1B9594EE-359F-4060-A037-B2A8715394B4Q37953819-79D7AC85-4E1C-4355-A6E2-F272A2259FC2Q38268267-EAD41096-80A1-4E3C-85AE-34CB5507EFD9Q38535106-3FD3BC15-D948-414B-A209-A3427830EBF0Q44833296-C317291A-A427-4B2F-9BE6-06E325421B90Q46230389-EEDA361A-4977-4652-BE55-1FC2D4141B0DQ46552680-384296CD-91B3-468D-83DB-A67DBA84AAA9Q47102932-CCA92FB0-5D3E-430C-BDCA-8D790593D824Q47222891-FCF6482A-AAF5-4264-8B22-764C8F739707Q51358591-EBB91CAD-44AF-4B7F-9014-A2E4BB4B3E26Q53671313-9E9AFBC2-53FA-4D88-AA73-E31BB3A96CD6Q58811102-CC379091-3B30-481D-8D05-A38672C47B92
P2860
Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@en
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@nl
type
label
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@en
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@nl
prefLabel
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@en
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@nl
P2093
P356
P1476
Comparison of efficacy of spir ...... ndrome: an open-labeled study.
@en
P2093
A C Ammini
M Ashraf Ganie
M L Khurana
S N Dwivedi
P304
P356
10.1210/JC.2003-031780
P407
P577
2004-06-01T00:00:00Z